OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8223 for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716 and PR 7017630307. The total contract value is $130.80, with the award issued on July 24, 2026, and issued as a delivery order under the parent contract SPE2DX25D9900. The awardee, identified by CAGE code 1UNB0, is a federal supplier fulfilling a requirement for the Department of Defense. The contract specifies only one line item, focusing solely on the procurement of this specific extended-release capsule formulation, with no indication of set-aside status, NAICS code, or detailed place of performance beyond the United States. All information is accessible via the DIBBS portal using the provided UI link.
General Info
Agency
Contract Value
$130.8NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
